GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Rafina Innovations Inc (OTCPK:VICA) » Definitions » Debt-to-EBITDA

Rafina Innovations (Rafina Innovations) Debt-to-EBITDA : -0.05 (As of Mar. 2019)


View and export this data going back to 2008. Start your Free Trial

What is Rafina Innovations Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Rafina Innovations's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2019 was $0.13 Mil. Rafina Innovations's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2019 was $0.00 Mil. Rafina Innovations's annualized EBITDA for the quarter that ended in Mar. 2019 was $-2.42 Mil. Rafina Innovations's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2019 was -0.05.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Rafina Innovations's Debt-to-EBITDA or its related term are showing as below:

VICA's Debt-to-EBITDA is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.26
* Ranked among companies with meaningful Debt-to-EBITDA only.

Rafina Innovations Debt-to-EBITDA Historical Data

The historical data trend for Rafina Innovations's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rafina Innovations Debt-to-EBITDA Chart

Rafina Innovations Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.02 -0.09 - -0.02 -0.01

Rafina Innovations Quarterly Data
Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.29 -0.02 -0.06 -0.01 -0.05

Competitive Comparison of Rafina Innovations's Debt-to-EBITDA

For the Medical Devices subindustry, Rafina Innovations's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rafina Innovations's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Rafina Innovations's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Rafina Innovations's Debt-to-EBITDA falls into.



Rafina Innovations Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Rafina Innovations's Debt-to-EBITDA for the fiscal year that ended in Dec. 2018 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.079 + 0) / -5.764
=-0.01

Rafina Innovations's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2019 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.126 + 0) / -2.416
=-0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2019) EBITDA data.


Rafina Innovations  (OTCPK:VICA) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Rafina Innovations Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Rafina Innovations's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Rafina Innovations (Rafina Innovations) Business Description

Traded in Other Exchanges
N/A
Address
9 Karpenisiou, Strovolos Lefkosias, CYP, 2021
Rafina Innovations Inc through its subsidiaries is involved in the development of monitoring technologies, set up of rehabilitation centers, development of intellectual property related to everyday fields such as healthcare, sports, automotive and gaming as well as the creation of full-service Prosthetics and Orthotics and Diabetic foot clinics chain in Europe and the Middle East. The firm's main products include Flexisense technology and Rehabilitation clinics etc. It has Clinics and Technology operating segments and derives a majority of its revenues from Clinics segment.

Rafina Innovations (Rafina Innovations) Headlines